Utility of the plasma level of suPAR in monitoring risk of mortality during TB treatment

Paulo Rabna, Andreas Andersen, Christian Wejse, Ines Oliveira, Victor Francisco Gomes, Maya Bonde Haaland, Peter Aaby, Jesper Eugen-Olsen

17 Citationer (Scopus)

Abstract

To investigate whether changes in the plasma level of soluble urokinase plasminogen activator receptor (suPAR) can be used to monitor tuberculosis (TB) treatment efficacy.
OriginalsprogEngelsk
TidsskriftP L o S One
Vol/bind7
Udgave nummer8
Sider (fra-til)e43933
ISSN1932-6203
DOI
StatusUdgivet - 2012

Fingeraftryk

Dyk ned i forskningsemnerne om 'Utility of the plasma level of suPAR in monitoring risk of mortality during TB treatment'. Sammen danner de et unikt fingeraftryk.

Citationsformater